Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial.
Saved in:
| Title: | Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial. |
|---|---|
| Authors: | Sherratt-Mayhew S; University of Birmingham Medical School, School of Medical Sciences, University of Birmingham, Birmingham, UK., Page C; University of Birmingham Medical School, School of Medical Sciences, University of Birmingham, Birmingham, UK., Lowe M; Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK., Labella Alvarez F; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.; Department of Morphological and Socio-Sanitary Sciences, Córdoba University School of Medicine and Nursing, Córdoba, Andalusia, Spain., Mollan SP; Metabolism and Systems Science, School of Medical Sciences, University of Birmingham, Birmingham, UK. s.mollan.1@bham.ac.uk., Berman G; Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. |
| Source: | Eye (London, England) [Eye (Lond)] 2025 Sep 19. Date of Electronic Publication: 2025 Sep 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
